Astral / Q4-FY24

Read the quarter in context.

A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

Positive2024-05-15Back to ASTRAL

Revenue

₹1,625 Cr

verified against source

Revenue YoY

reported change

EBITDA

Pending

latest reported figure

Source

screener in

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
EBITDA (₹ Cr)PositiveWatchNegative
2 actual records
Actual quarterly EBITDA (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q2 FY25: 219 · Watch source sentiment · 2024-11-01Q2 FY25Q3 FY26: 247 · Positive source sentiment · 2026-02-15Q3 FY26247219
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

Astral reported a strong year with piping volume growth of ~23% and adhesive India revenue of INR 960 crore at 15.7% EBITDA margin. The company is expanding capacity with two new pipe plants (Hyderabad, Kanpur) and entering OPVC pipes with proprietary low-CapEx technology. Paints and Bathware are scaling: paints targeting INR 300+ crore in FY25 with 14-15% EBITDA, Bathware aiming for INR 125-150 crore and breakeven. Key risks include polymer price volatility and execution in new verticals. Management guides 15-20% volume growth for pipes and 20%+ for India adhesives, with potential upside from polymer price recovery and market share gains.

Colored figures show movement against the previous available record.

Guidance to track

  • Management guides 15-20% volume growth for pipes, with potential upward revision after H1 based on polymer price and demand trends.
  • Paints business targets INR 300+ crore revenue in FY25 with EBITDA margin of 14-15%, leveraging Astral brand and distribution.
  • Bathware business aims to achieve revenue of INR 125-150 crore and turn EBITDA positive in FY25.
  • Planned CapEx of INR 250 crore for pipes (Hyderabad and Kanpur plants) and INR 50 crore for other businesses, with potential increase if demand is robust.

Risks flagged

  • Sharp polymer price increases (10% in Q1) could compress margins if not passed through, though management sees it as positive for organized players.
  • Paints and Bathware are still in early stages; achieving revenue and margin targets depends on successful brand building and distribution ramp-up.
  • UK adhesive EBITDA halved to INR 19 crore due to inventory losses; management expects 10% margin but recovery is uncertain.
  • Entry of a major cement player and price cuts by incumbents could pressure Astral's paint margins and market share.

Key quotes

  • We are not here to do magic, but next year, our target is INR 300 crores plus, around that, in paints, and we'll deliver this number.
  • Our OPVC CapEx, typically, we are going to invest 1/4 of what our peers have invested in OPVC.
  • We are very clear that we don't want to do the business at the cost of balance sheet, so we are very clear. We will be happy with 1% or 2% lesser growth, but we will not dilute our balance sheet.

Research modules

Go one layer deeper.